AAIPharma Services Corp. (“AAIPharma”) a leading global provider of pharmaceutical analytical testing product development and manufacturing services and Cambridge Major Laboratories Inc (“CML”) a global leader in pharmaceutical API development and manufacturing announce the appointment of Jeff Yuen as Executive Vice President Global Quality.
“Jeff’s addition to our team helps demonstrate our commitment to being a world-class full service CMC provider” said Patrick Walsh Chief Executive Officer. “Jeff has nearly thirty (30) years of experience and is widely recognized as an expert in Good Manufacturing Practices (GMP) and compliance in the pharmaceutical industry. His breadth of knowledge in the areas of active pharmaceutical ingredients sterile drug manufacturing and biotechnology products aligns perfectly with our company’s key service offerings.”
Mr. Yuen has served as Food and Drug Investigator at the State of California Department of Health Services Food and Drug Branch; several roles at the U.S. Food and Drug Administration (FDA) where he was promoted to the rank of Commander in the U.S. Public Health Service; and GMP Auditor GMP Advisor or FDA Advisory Committee member at NNFA (National Nutritional Foods Association now Natural Products Association or NPA) Dietary Supplement and BIOCOM. After leaving the FDA Jeff led a highly respected independent firm focused on expert FDA compliance and regulatory consulting for the dietary supplement pharmaceutical and biotechnology industries.
Mr. Yuen added “It is an honor to be part of such an excellent organization with a strong commitment to Quality. I look forward to many opportunities to help during this exciting phase.” Mr. Yuen earned an undergraduate degree in biological sciences from the University of California at Irvine (UCI) and a master’s degree in public health from the University of California at Los Angeles (UCLA). Jeff also earned a Master of Business Administration (MBA) degree from National University at Sacramento and Irvine.
About AAIPharma Services Corp. and Cambridge Major Laboratories Inc.
AAIPharma Services Corp. and Cambridge Major Laboratories Inc. have joined to form a world-class supplier of comprehensive pharmaceutical development and manufacturing services. With nearly 800 employees operating out of seven sites in the US and Europe combined capabilities include API development and manufacturing solid state chemistry formulation development analytical development and testing services clinical and commercial finished dosage form manufacturing (solid dose and parenteral) packaging and stability services. The family of companies is in the portfolio of American Capital Ltd. (NASDAQ: ACAS).
Last updated on: 27/01/2014